Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial

BACKGROUND: Idiopathic intracranial hypertension (IIH) is a condition with few effective management options. So far, there have been no randomized controlled trials evaluating new treatments in IIH. OBJECTIVES: The purpose of this paper is to outline the trial design for the Idiopathic Intracranial...

Descripción completa

Detalles Bibliográficos
Autores principales: Markey, Keira Annie, Ottridge, Ryan, Mitchell, James L, Rick, Caroline, Woolley, Rebecca, Ives, Natalie, Nightingale, Peter, Sinclair, Alexandra J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625129/
https://www.ncbi.nlm.nih.gov/pubmed/28923789
http://dx.doi.org/10.2196/resprot.7806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625129/
https://www.ncbi.nlm.nih.gov/pubmed/28923789
http://dx.doi.org/10.2196/resprot.7806

Ejemplares similares